TransMedics Group, Inc. (BIT:1TMDX)
Italy flag Italy · Delayed Price · Currency is EUR
110.00
0.00 (0.00%)
At close: Jul 11, 2025, 5:30 PM CET

TransMedics Group Company Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.

Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.

The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.

The company was founded in 1998 and is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.
CountryUnited States
Founded1998
IndustryElectromedical and Electrotherapeutic Apparatus
Employees728
CEOWaleed Hassanein

Contact Details

Address:
200 Minuteman Road
Andover, Massachusetts 01810
United States
Phone978 552 0900
Websitetransmedics.com

Stock Details

Ticker Symbol1TMDX
ExchangeBorsa Italiana
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3845

Key Executives

NamePosition
Waleed HassaneinChief Executive Officer
Gerardo HernandezChief Financial Officer
Nicholas CorcoranChief Operating Officer